Return to Reaganomics Seen Reviving U.K. Biotechnology

Though it has knowhow and wealth, the U.K. has never had much success creating biotechnology startups to rival such U.S. triumphs as Genentech Inc. and Amgen Inc. One explanation for this difference can be summed up in two words: Ronald Reagan.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.